[Multination clinical trials: what is the relevance and what are the lessons from across-country differences?]

Giornale Italiano Di Cardiologia (2006)
|May 31, 2014
PubMed

Insights

Multinational clinical trials require large patient populations due to effective cardiovascular treatments. Interpreting country-specific results demands cautious methodology and biological plausibility to avoid errors.

Area of Science:

  • Cardiovascular medicine
  • Clinical trial methodology

Background:

  • Evidence-based treatments have reduced cardiovascular events, necessitating large patient cohorts for research.
  • Multinational studies are now essential for robust clinical trial outcomes.

Purpose of the Study:

  • To highlight the challenges in interpreting country-specific results from multinational cardiovascular studies.
  • To emphasize the need for cautious interpretation of subgroup analyses in clinical trials.

Main Methods:

  • Discussion of methodologies for analyzing data from large-scale, multinational clinical trials.
  • Emphasis on the importance of biological plausibility and external validation for observed differences.

Main Results:

  • Differences in trial results across countries are common in cardiovascular research.
  • Inappropriate interpretation of these differences can lead to erroneous conclusions and flawed regulatory decisions.

Conclusions:

  • Interpreting country-specific variations in multinational trials requires rigorous statistical methods and biological rationale.
  • Further research and cross-study validation are crucial for reliable interpretation of clinical trial data.

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
8.5K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.7K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
627
Crossover Experiments01:16

Crossover Experiments

Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
3.4K
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
417
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
380